Adaphostin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAdaphostin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBcr-Abl tyrosine kinase inhibitors
TargetsBcr-Abl tyrosine kinase
Therapy Area/IndicationsMultiple MyelomaLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMayo ClinicNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteMayo Clinic
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaLeukemia, Myelogenous, Chronic

Other Information

ATC CodeN/A
Related LinksN/A